Figure 6: Pulmonary vascular analysis in hemopexin treated and untreated SCD mice experiencing progressive cardiopulmonary vascular disease.
(A) Right ventricular systolic pressures (B) Right ventricular afterload (C) Ventricular to vascular coupling ration (VVCR); (D) Pulmonary vascular thickening (E) Right ventricular weight (F)Fulton index a determinant of RV hypertrophy*p<0.05, †p<0.05 by t test.
